Guardant Health’s Shield Blood-based Screening Test for Colorectal Cancer Now Accessible Through National Test Ordering and Collection Network of Quest Diagnostics
Go back to Guardant Health’s Shield Blood-based Screening Test for Colorectal Cancer Now Accessible Through National Test Ordering and Collection Network of Quest Diagnostics| Textainer Group Holdings limited (NASDAQ: GH) | Delayed: 167.98 -2.79 (1.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $170.77 | 52 Week High | $5.84 | |||
| Open | $171.96 | 52 Week Low | $5.49 | |||
| Day High | $171.99 | P/E | N/A | |||
| Day Low | $166.74 | EPS | $0.00 | |||
| Volume | 3,455,313 | |||||
